Andrea Deabreu

Sunnybrook Health Science Centre — Canada

Medicine · Health Sciences

23h-index1.5kcitations110works0.92yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(98), Prostate Cancer Treatment and Research(97), Advanced Radiotherapy Techniques(68), Bladder and Urothelial Cancer Treatments(4), Radiation Therapy and Dosimetry(4)

Publications110 total

FEASIBILITY OF INTEGRATING RECTAL HYDROGEL SPACER FOR SALVAGE TREATMENT USING STEREOTACTIC ABLATIVE BODY RADIOTHERAPY FOR LOCALLY RECURRENT PROSTATE CANCER
Radiotherapy and Oncology·2025
Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective study
Radiotherapy and Oncology·2025
3203 Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective study
Radiotherapy and Oncology·2025
Every Other Day or Once a Week: Long-term Oncological Outcomes in the Phase 2 PATRIOT Trial of Prostate Stereotactic Ablative Body Radiotherapy
European Urology Oncology·2025Open Access
PSOR08 Presentation Time: 12:05 PM
Brachytherapy·2024
Stereotactic Radiation Therapy for Localized Prostate Cancer: 10-Year Outcomes From Three Prospective Trials
International Journal of Radiation Oncology*Biology*Physics·2024· 8 cited
72 Local Relapse Patterns After MR-Assisted Salvage HDR Prostate Brachytherapy: A Prospective Study
Radiotherapy and Oncology·2024
1931: Local relapse patterns after MR-assisted salvage HDR prostate brachytherapy: a prospective study
Radiotherapy and Oncology·2024
454: SABR for favourable-risk prostate cancer: 10-year outcomes and second malignancies
Radiotherapy and Oncology·2024
Every-other-day or once-a-week: Long-term efficacy outcomes of the multicenter randomised PATRIOT prostate SBRT trial.
Journal of Clinical Oncology·2024· 1 cited
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT)
International Journal of Radiation Oncology*Biology*Physics·2023· 5 cited
Dosimetric Predictors of Toxicities and Quality of Life Following Two-Fraction Stereotactic Body Radiotherapy for Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2023
131 A Prospective Study of MR-Assisted Salvage HDR Prostate Brachytherapy with Intra-Prostatic Boost
Radiotherapy and Oncology·2023
PL02  Presentation Time: 1:45 PM
Brachytherapy·2023
PP06  Presentation Time: 11:45 AM
Brachytherapy·2023
Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer
Radiotherapy and Oncology·2023· 7 cited
To Boost or Not to Boost: Pooled Analyses From 2-Fraction SABR Trials for Localized Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2023· 10 cited
OC-0925 2-fraction prostate SABR+/-dominant intraprostatic lesions boost: results from two Phase II trials
Radiotherapy and Oncology·2023
Contents
Radiotherapy and Oncology·2023Open Access
Two-fraction stereotactic MRI-guided ablative radiotherapy with simultaneous boost to dominant intraprostatic lesion: Results from the 2SMART phase 2 trial.
Journal of Clinical Oncology·2023
page 1 of 6Next →

Frequent Co-authors

Patrick Cheung(43), Alexandre Mamedov(36), Andrew Loblaw(35), Hans T. Chung(35), Liying Zhang(34), William Chu(27), Gerard Morton(26), Ananth Ravi(25), Danny Vesprini(24), Melanie Davidson(24), Laura D’Alimonte(22), Geordi Pang(20), Harvey Quon(18), Hima Bindu Musunuru(15), Stanley K. Liu(15), Joelle Helou(14), D.A. Loblaw(13), Yasir Alayed(10), Dilip Panjwani(9), Cyril Danjoux(8)